Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. J.D. Lefrandt

Publicaties

Change in telomere length and cardiovascular risk factors in testicular cancer survivors

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life

Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study

Physical exercise in patients with testicular cancer treated with bleomycin, etoposide and cisplatin chemotherapy - pulmonary and vascular endothelial function: an exploratory analysis

Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy

Shared-care survivorship program for testicular cancer patients: safe and feasible

Cardiovascular effects of overt and subclinical hyperthyroidism: focus on differentiated thyroid cancer

Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment

Lees meer